Abstract:Ethnopharmacological relevance: Ginsenosides are natural product steroid glycosides and triterpene saponins obtained from the Panax species. Panax ginseng has been widely used as a traditional Chinese medicine (TCM) for around a thousand years, especially in East Asian countries. Ginseng, the root and rhizome of the most popular species P. ginseng, used as tonic, prophylactic agent and restorative. In TCM, ginseng is highly valued herb and has been applied to a variety of pathological conditions and illnesses such as hypodynamia, anorexia, shortness of breath, palpitation, insomnia, impotence, hemorrhage and diabetes.Aim of the study: The basic aim of this study was to evaluate the anti-Alzheimer's disease activities of selected ginsenosides (Rb1, Rb2, Rc, Re, Rg1, and Rg3) according to peroxynitrite (ONOO-) scavenging activity and inhibitory activity of ONOO--mediated nitrotyrosine formation as a measure of changes in oxidative stress. In addition, molecular docking simulation studies were performed to predict binding energies of the ginsenosides with (3-site amyloid precursor protein cleaving enzyme 1 (BACE1, beta- secretase) and identify the interacting residues.Materials and methods: In vitro cholinesterase enzyme assays by using acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and BACE1 were performed. In vitro authentic peroxynitrite scavenging activity and inhibitory activity against ONOO--mediated nitrotyrosine formation were also performed. Molecular docking simulation studies were performed with Autodock Vina software and Discovery studio 4.1.Results: In vitro enzyme assays demonstrated that ginsenosides have significant inhibitory potential against AChE, BChE, and BACE1, as well as ONOO- and nitrotyrosine formation. Most importantly, significant AChE inhibitory activities were observed for Re; BChE for Rg3; and BACE1 for Rc, with IC50 values of 29.86 +/- 3.20, 16.80 +/- 0.36, and 59.81 +/- 2.74 mu g/mL, respectively. Among the tested ginsenosides, Rbl exhibited a higher scavenging activity against ONOO- with an IC50 value of 27.86 +/- 1.34 mu g/mL, while Rc and Rg3 exhibited impressive inhibitory activity against the formation of nitrotyrosine. In addition, molecular docking studies revealed potential BACE1 inhibitory activity of ginsenosides, especially Rbl and Rb2, which exhibited good binding affinities towards BACE1, with docking scores of 10 kcal/mol.Conclusion: The findings of the present study suggest the potential of ginsenosides (Rbl, Rb2, Rc, Re, Rg1, and Rg3) for use in the development of therapeutic or preventive agents for Alzheimer's disease, especially through inhibition of AChE, BChE and BACE1 activities, as well as scavenging of ONOO- and inhibition of nitrotyrosine formation. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Heterologous expression of BACE1 and its interaction with Codonopsis pilosula polysaccharides and Lobetyolin

Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer's disease

Progress in the Development of Nonpeptidomimetic BACE 1 Inhibitors for Alzheimers Disease

Identification Of Novel Bace1 Inhibitors By Combination Of Pharmacophore Modeling, Structure-Based Design And In Vitro Assay

In Silico Design of BACE1 Inhibitor for Alzheimer's Disease by Traditional Chinese Medicine.

Modulation of the Aβ-Peptide-Aggregation Pathway by Active Compounds From Platycladus orientalis Seed Extract in Alzheimer's Disease Models

Modulation of the Aβ-Peptide-Aggregation Pathway by Active Compounds From Platycladus orientalis Seed Extract in Alzheimer’s Disease Models

Revealing the Binding Mechanism of BACE1 Inhibitors Through Molecular Dynamics Simulations.

Molecular mechanism underlying effect of D93 and D289 protonation states on inhibitor-BACE1 binding: exploration from multiple independent Gaussian accelerated molecular dynamics and deep learning

SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer's disease amyloidosis and improves synaptic function.

P1-385: Protection against beta-amyloid-induced synaptic impairments via promotion of beta-amyloid oligomer aggregation by bis(heptyl)-cognitin

Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer's disease

The Effect of BACE1-AS on Β-Amyloid Generation by Regulating BACE1 Mrna Expression

Bacopa monnieri phytochemicals as promising BACE1 inhibitors for Alzheimers Disease Therapy

BACE1 controls synaptic function through modulating release of synaptic vesicles

BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.

Molecular Mechanism of Binding Selectivity of Inhibitors Toward BACE1 and BACE2 Revealed by Multiple Short Molecular Dynamics Simulations and Free-Energy Predictions.

A novel two-photon ratiometric fluorescent probe for imaging and sensing of BACE1 in different regions of AD mouse brain

O4‐02‐01: A Novel Role of Beta‐secretase1 (BACE1) in the Pathogenesis of Cerebral Amyloid Angiopathy (CAA)

DNA Aptamers Targeting BACE1 Reduce Amyloid Levels and Rescue Neuronal Deficiency in Cultured Cells

Polysaccharides from Lycium Barbarum Ameliorate Amyloid Pathology and Cognitive Functions in APP/PS1 Transgenic Mice.